Abstract
Lymphedema is one of the main late effects from breast cancer treatment affecting 3–60 % of breast cancer survivors. Primarily occurring in the hand, arm, and/or affected breast, symptoms of lymphedema include swelling, pain, redness, restriction of arm/hand movement, tightness and feelings of fullness. These symptoms not only may limit physical functioning but also negatively affect quality of life, body image, social functioning, and financial status of breast cancer survivors with lymphedema. Unfortunately, there are no standardized methods for prevention, diagnosis, and treatment of breast cancer-related lymphedema. Despite its prevalence and lack of clinical guidelines, lymphedema is one of the most poorly understood, relatively underestimated, and least researched complications of cancer treatment. This chapter reviews the current problem of breast cancer-related lymphedema by investigating prevention and risk reduction strategies, diagnosis, and treatment. In addition, this chapter identifies future research opportunities focusing on prevention and risk reduction strategies, quality of life and physical function, surveillance, patient education, cost, diagnosis, and treatment. Challenges and recommendations for future research in these areas, particularly among underserved populations, are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adriaenssens N, Belsack D, Buyl R et al (2012) Ultrasound elastography as an objective diagnostic measurement tool for lymphoedema of the treated breast in breast cancer patients following breast conserving surgery and radiotherapy. Radiol Oncol 46:284–295
Ahmed RL, Thomas W, Yee D, Schmitz KH (2006) Randomized controlled trial of weight training and lymphedema in breast cancer survivors. J Clin Oncol 24:2765–2772
American Cancer Society (2013) Breast cancer facts & figures 2013–2014. American Cancer Society, Atlanta, GA
Armer J, Fu MR (2005) Age differences in post-breast cancer lymphedema signs and symptoms. Cancer Nurs 28:200–207
Armer JM, Brooks CW, Stewart BR (2011) Limitations of self-care in reducing the risk of lymphedema: supportive-educative systems. Nurs Sci Q 24:57–63
Armer J, Hulett J, Bernas M, Ostby P, Stewart BR, Cormier JN (2013) Best-practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema. Curr Breast Cancer Rep 5:134–144
Arrington AK, Kruper L, Vito C, Yim J, Kim J, Chen SL (2013) Rural and urban disparities in the evolution of sentinel lymph node utilization in breast cancer. Am J Surg 206:674–681
Badger CM, Peacock JL, Mortimer PS (2000) A randomized, controlled, parallel-group clinical trial comparing multilayer bandaging followed by hosiery versus hosiery alone in the treatment of patients with lymphedema of the limb. Cancer 88:2832–2837
Bae H, Kim HJ (2013) Clinical outcomes of extracorporeal shock wave therapy in patients with secondary lymphedema: a pilot study. Ann Rehabil Med 37:229–234
Bernas M (2013) Assessment and risk reduction in lymphedema. Semin Oncol Nurs 29:12–19
Bernas M, Askew RL, Armer J, Cormier JN (2010) Lymphedema: how do we diagnose and reduce the risk of this dreaded complication of breast cancer treatment? Curr Breast Cancer Rep 2:53–58
Cassileth BR, Van Zee KJ, Yeung KS et al (2013) Acupuncture in the treatment of upper-limb lymphedema: results of a pilot study. Cancer 119:2455–2461
Chen YW, Tsai HJ, Hung HC, Tsauo JY (2008) Reliability study of measurements for lymphedema in breast cancer patients. Am J Phys Med Rehabil 87:33–38
Clark B, Sitzia J, Harlow W (2005) Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. QJM 98:343–348
Cormie P, Galvao DA, Spry N, Newton RU (2013) Neither heavy nor light load resistance exercise acutely exacerbates lymphedema in breast cancer survivor. Integr Cancer Ther 12:423–432
Cormier JN, Xing Y, Zaniletti I, Askew RL, Stewart BR, Armer JM (2009) Minimal limb volume change has a significant impact on breast cancer survivors. Lymphology 42:161–175
Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM (2010) Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer 116:5138–5149
Cornish BH, Chapman M, Hirst C et al (2001) Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology 34:2–11
Courneya KS, Segal RJ, Mackey JR et al (2007) Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 25:4396–4404
Czerniec SA, Ward LC, Refshauge KM et al (2010) Assessment of breast cancer-related arm lymphedema–comparison of physical measurement methods and self-report. Cancer Invest 28:54–62
Dayes IS, Whelan TJ, Julian JA et al (2013) Randomized trial of decongestive lymphatic therapy for the treatment of lymphedema in women with breast cancer. J Clin Oncol 31:3758–3763
Dehal A, Abbas A, Johna S (2013) Racial disparities in clinical presentation, surgical treatment and in-hospital outcomes of women with breast cancer: analysis of nationwide inpatient sample database. Breast Cancer Res Treat 139:561–569
Deutsch M, Land S, Begovic M, Sharif S (2008) The incidence of arm edema in women with breast cancer randomized on the national surgical adjuvant breast and bowel project study B-04 to radical mastectomy versus total mastectomy and radiotherapy versus total mastectomy alone. Int J Radiat Oncol Biol Phys 70:1020–1024
DiSipio T, Hayes SC, Newman B, Aitken J, Janda M (2010) Does quality of life among breast cancer survivors one year after diagnosis differ depending on urban and non-urban residence? A comparative study. Health Qual Life Outcomes 8:3
Dominick SA, Madlensky L, Natarajan L, Pierce JP (2013) Risk factors associated with breast cancer-related lymphedema in the WHEL Study. J Cancer Surviv 7:115–123
Erickson VS, Pearson ML, Ganz PA, Adams J, Kahn KL (2001) Arm edema in breast cancer patients. J Natl Cancer Inst 93:96–111
Fife CE, Davey S, Maus EA, Guilliod R, Mayrovitz HN (2012) A randomized controlled trial comparing two types of pneumatic compression for breast cancer-related lymphedema treatment in the home. Support Care Cancer 20:3279–3286
Fu MR, Ryan JC, Cleeland CM (2012) Lymphedema knowledge and practice patterns among oncology nurse navigators. J Oncol Navig Surviv 3(4):9–15
Fu MR, Ridner SH, Hu SH, Stewart BR, Cormier JN, Armer JM (2013) Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011. Psychooncology 22:1466–1484
Golshan M, Smith B (2006) Prevention and management of arm lymphedema in the patient with breast cancer. J Support Oncol 4:381–386
Graham PH (2002) Compression prophylaxis may increase the potential for flight-associated lymphedema after breast cancer treatment. Breast 11(1):66–71
Hayes SC, Janda M, Cornish B, Battistuatta D, Newman B (2008) Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol 26(21):3536–3542
Huang TW, Tseng SH, Lin CC et al (2013) Effects of manual lymphatic drainage on breast cancer-related lymphedema: a systematic review and meta-analysis of randomized controlled trials. World J Surg Oncol 11:15
Jammallo LS, Miller CL, Singer M (2013) Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer. Breast Cancer Res Treat 142:59–67
Johansson K, Branje E (2010) Arm lymphoedema in a cohort of breast cancer survivors 10 years after diagnosis. Acta Oncol 49:166–173
Jonsson C, Johansson K (2009) Pole walking for patients with breast cancer-related arm lymphedema. Physiother Theory Pract 25:165–173
Katz E, Dugan NL, Cohn JC, Chu C, Smith RG, Schmitz KH (2010) Weight lifting in patients with lower-extremity lymphedema secondary to cancer: a pilot and feasibility study. Arch Phys Med Rehabil 91:1070–1076
Kilbreath SL, Ward LC, Lane K, McNeely M, Dylke ES et al (2010) Effect of air travel on lymphedema risk in women with history of breast cancer. Breast Cancer Res Treat 120:649–654
King M, Deveaux A, White H, Rayson D (2012) Compression garments versus compression bandaging in decongestive lymphatic therapy for breast cancer-related lymphedema: a randomized controlled trial. Support Care Cancer 20:1031–1036
Mak SS, Yeo W, Lee YM et al (2008) Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong. Nurs Res 57:416–425
McLaughlin SA, Wright MJ, Morris KT et al (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26:5213–5219
McLaughlin SA, Bagaria S, Gibson T et al (2013) Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgery. J Am Coll Surg 216:380–389
McNeely ML, Campbell K, Ospina M (2010) Exercise interventions for upper-limb dysfunction due to breast cancer treatment. Cochrane Database Syst Rev 6, CD005211
McWayne J, Heiney SP (2005) Psychologic and social sequelae of secondary lymphedema: a review. Cancer 104:457–466
Meeske KA, Sullivan-Halley J, Smith AW (2009) Risk factors for arm lymphedema following breast cancer diagnosis in black women and white women. Breast Cancer Res Treat 113:383–391
Meneses KD, McNees P, Loerzel VW, Su X, Zhang Y, Hassey LA (2007) Transition from treatment to survivorship: effects of a psychoeducational intervention on quality of life in breast cancer survivors. Oncol Nurs Forum 34:1007–1016
Mortimer PS (1998) The pathophysiology of lymphedema. Cancer 83:2798–2802
Moshiri M, Katz DS, Boris M, Yung E (2002) Using lymphoscintigraphy to evaluate suspected lymphedema of the extremities. AJR Am J Roentgenol 178:405–412
Norman SA, Localio AR, Potashnik SL (2009) Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol 27:390–397
Ogden CL, Carroll MD, Kit KB, Flegal KM (2012) Prevalence of obesity in the United States, 2009–2010. NCHS data brief 82:1–8
O’Toole J, Jammallo LS, Skolny MN et al (2013) Lymphedema following treatment for breast cancer: a new approach to an old problem. Crit Rev Oncol Hematol 88:437–446
Ozaslan C, Kuru B (2004) Lymphedema after treatment of breast cancer. Am J Surg 187:69–72
Park JE, Jang HJ, Seo KS (2012) Quality of life, upper extremity function and the effect of lymphedema treatment in breast cancer related lymphedema patients. Ann Rehabil Med 36:240–247
Paskett ED, Dean JA, Oliveri JM, Harrop JP (2012) Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review. J Clin Oncol 30:3726–3733
Ridner SH, Dietrich MS, Stewart BR, Armer JM (2011) Body mass index and breast cancer treatment-related lymphedema. Support Care Cancer 19:853–857
Ridner SH, Deng J, Fu MR et al (2012) Symptom burden and infection occurrence among individuals with extremity lymphedema. Lymphology 45:113–123
Rockson SG (2012) Update on the biology and treatment of lymphedema. Curr Treat Options Cardiovasc Med 14:184–192
Rourke LL, Hunt KK, Cormier JN (2010) Breast cancer and lymphedema: a current overview for the healthcare provider. Womens Health 6:399–406
Sagen A, Karesen R, Skaane P, Risberg MA (2009) Validity for the simplified water displacement instrument to measure arm lymphedema as a result of breast cancer surgery. Arch Phys Med Rehabil 90:803–809
Sayko O, Pezzin LE, Yen TW, Nattinger AB (2013) Diagnosis and treatment of lymphedema after breast cancer: a population-based study. PM R 5:915–923
Schmitz KH (2010) Balancing lymphedema risk: exercise versus deconditioning for breast cancer survivors. Exerc Sport Sci Rev 38:17–24
Schmitz KH, Ahmed RL, Troxel A (2009) Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med 361:664–673
Schmitz KH, Ahmed RL, Troxel AB et al (2010) Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA 304:2699–2705
Schwartz AL (2012) Safety, injury prevention, and emergency procedures. In: Irwin ML (ed) ACSM’s guide to exercise and cancer survivorship. Human Kinetics, Champaign, IL, p 153–160
Shah C, Vicini FA (2011) Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies. Int J Radiat Oncol Biol Phys 81:907–914
Shah C, Arthur D, Riutta J, Whitworth P, Vicini FA (2012a) Breast-cancer related lymphedema: a review of procedure-specific incidence rates, clinical assessment AIDS, treatment paradigms, and risk reduction. Breast J 18:357–361
Shah C, Wilkinson JB, Baschnagel A et al (2012b) Factors associated with the development of breast cancer-related lymphedema after whole-breast irradiation. Int J Radiat Oncol Biol Phys 83:1095–1100
Sherman KA, Koelmeyer L (2011) The role of information sources and objective risk status on lymphedema risk-minimization behaviors in women recently diagnosed with breast cancer. Oncol Nurs Forum 38:E27–E36
Shigaki CL, Madsen R, Wanchai A, Stewart BR, Armer JM (2013) Upper extremity lymphedema: presence and effect on functioning five years after breast cancer treatment. Rehabil Psychol 58:342–349
Shih YC, Xu Y, Cormier JN et al (2009) Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 27:2007–2014
Sierla R, Lee TS, Black D, Kilbreath SL (2013) Lymphedema following breast cancer: regions affected, severity of symptoms, and benefits of treatment from the patients’ perspective. Clin J Oncol Nurs 17:325–331
Soran A, D’Angelo G, Begovic M et al (2006) Breast cancer-related lymphedema – what are the significant predictors and how they affect the severity of lymphedema? Breast J 12:536–543
Soran A, Finegold DN, Brufsky A (2012) Lymphedema prevention and early intervention: a worthy goal. Oncol 26:249, 254, 256
Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P (2008) Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer 112:2809–2819
Stout NL, Pfalzer LA, Levy E et al (2011) Segmental limb volume change as a predictor of the onset of lymphedema in women with early breast cancer. PM R 3:1098–1105
Stout NL, Pfalzer LA, Springer B et al (2012) Breast cancer-related lymphedema: comparing direct costs of a prospective surveillance model and a traditional model of care. Phys Ther 92:152–163
Stout NL, Weiss R, Feldman JL et al (2013) A systematic review of care delivery models and economic analyses in lymphedema: health policy impact (2004–2011). Lymphology 46:27–41
Szuba A, Strauss W, Sirsikar SP, Rockson SG (2002) Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancer-related lymphedema of the upper extremity. Nucl Med Commun 23:1171–1175
Tam EK, Shen L, Munneke JR (2012) Clinician awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery setting. Breast Cancer Res Treat 131:1029–1038
Vignes S, Blanchard M, Arrault M, Porcher R (2013) Intensive complete decongestive physiotherapy for cancer-related upper-limb lymphedema: 11 days achieved greater volume reduction than 4. Gynecol Oncol 131:127–130
Ward LC, Bunce IH, Cornish BH, Mirolo BR, Thomas BJ, Jones LC (1992) Multi-frequency bioelectrical impedance augments the diagnosis and management of lymphoedema in post-mastectomy patients. Eur J Clin Invest 22:751–754
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Breast Cancer Research Foundation
About this chapter
Cite this chapter
Paskett, E.D. (2015). Symptoms: Lymphedema. In: Ganz, P. (eds) Improving Outcomes for Breast Cancer Survivors. Advances in Experimental Medicine and Biology(), vol 862. Springer, Cham. https://doi.org/10.1007/978-3-319-16366-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-16366-6_8
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-16365-9
Online ISBN: 978-3-319-16366-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)